Press releases | WebDisclosure

Basculer en Français

10964	Companies
239949	Keywords
168718	Articles
129095	Press releases

Home
Press releases

PRESS RELEASE

published on 05/08/2024 at 10:00, 2 years 4 months ago

Sto SE & Co. KGaA: Consolidated turnover down by 5.9 % in the first quarter of 2024 compared to the same period of the previous year
Sto SE & Co. KGaA reports a 5.9% decrease in consolidated turnover in Q1 2024 compared to the previous year due to weather conditions and lower investment in the building industry

Financial Report Q1 2024 Sto SE & Co. KGaA Consolidated Turnover Building Industry
PRESS RELEASE

published on 05/08/2024 at 09:02, 2 years 4 months ago

Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): Kaufen
Borussia Dortmund secures profits with UEFA advancements. Secure 5th place in Bundesliga ensures Champions League participation. Revenue decrease in Q3 prelims. Executive board changes announced. Buy recommendation with target price of EUR 5.50

Revenue Decrease Borussia Dortmund Champions League UEFA Executive Board Changes
PRESS RELEASE

published on 05/08/2024 at 09:01, 2 years 4 months ago

Original-Research: Westwing Group SE (von NuWays AG): Kaufen
Westwing Group SE veröffentlicht starke Q1-Ergebnisse und bestätigt Jahresprognose. Positive Entwicklung von GMV und EBITDA. Aktienempfehlung: Kaufen

Westwing Group SE Adj. EBITDA Q1-Ergebnisse Jahresprognose GMV-Wachstum
PRESS RELEASE

published on 05/08/2024 at 09:00, 2 years 4 months ago

Inside Information / Other news releases
Medincell suspends listing of shares on Euronext Paris pending press release. Innovative biopharmaceutical company developing long-acting injectable drugs

Euronext Paris Biopharmaceutical Suspension Medincell Long-acting Injectable Drugs
PRESS RELEASE

published on 05/08/2024 at 09:00, 2 years 4 months ago

Informations privilégiées / Autres communiqués
Medincell suspend la cotation de ses actions sur Euronext Paris, en attente de la publication d'un communiqué. Reprise des négociations prévue demain

Euronext Paris Cotation Suspension Medincell Communiqué
PRESS RELEASE

published on 05/08/2024 at 08:59, 2 years 4 months ago

RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter
RHÖN-KLINIKUM AG reports a strong start to financial year 2024 with increased revenues and profits in Q1. The outlook for 2024 confirms positive expectations despite regulatory challenges

Revenues Financial Year 2024 Outlook RHÖN-KLINIKUM AG Profits
PRESS RELEASE

published on 05/08/2024 at 08:56, 2 years 4 months ago

Edison issues review on Canadian General Investments (CGI): Adding to positive long-term performance record
Edison issues positive review on Canadian General Investments (CGI) for its long-term performance record, highlighting strategic stock selection and dividend policy

Edison Investment Research Limited Dividend Policy Canadian General Investments Long-term Performance Stock Selection
PRESS RELEASE

published on 05/08/2024 at 08:50, 2 years 4 months ago

Change in the Supervisory Board of DEMIRE: Ernö Theuer succeeds Prof. Dr. Kerstin Hennig
DEMIRE Deutsche Mittelstand Real Estate AG announces Ernö Theuer as the new member of its Supervisory Board, succeeding Prof. Dr. Kerstin Hennig

DEMIRE Deutsche Mittelstand Real Estate AG Supervisory Board Ernö Theuer CRESPI Group Prof. Dr. Kerstin Hennig
PRESS RELEASE

published on 05/08/2024 at 08:31, 2 years 4 months ago

Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024. Des nouvelles données seront partagées concernant le candidat médicament obefazimod

Abivax Obefazimod Rectocolite Hémorragique Digestive Disease Week Cancer Du Côlon
PRESS RELEASE

published on 05/08/2024 at 08:31, 2 years 4 months ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax presents four abstracts on obefazimod for ulcerative colitis and colon cancer model at Digestive Disease Week 2024. The company highlights novel mechanism of action and positive clinical data for obefazimod

Abivax Obefazimod Ulcerative Colitis Digestive Disease Week Colon Cancer

Accesswire

Published on 09/10/2026 at 17:46, 3 hours 53 minutes ago

Groete Access Road Nears Completion
Published on 09/10/2026 at 15:20, 6 hours 19 minutes ago

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 6 hours 39 minutes ago

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/10/2026 at 14:37, 7 hours 2 minutes ago

Worksport (NASDAQ:WKSP) Invites Shareholders to September 15 CEO Town Hall
Published on 09/10/2026 at 14:30, 7 hours 9 minutes ago

Solitario Resources CEO to Present at HC Wainwright 28th Annual Global Investment Conference

View all ACCESSWIRE

EQS Group

Published on 09/10/2026 at 21:25, 14 minutes ago

Ørsted receives final opinion regarding taxation of Walney Extension and Hornsea 1
Published on 09/10/2026 at 19:35, 2 hours 4 minutes ago

EQS-Adhoc: United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/10/2026 at 19:21, 2 hours 18 minutes ago

EQS-Adhoc: IONOS Group SE launches strategic transformation program and strengthens growth foundation
Published on 09/10/2026 at 19:00, 2 hours 39 minutes ago

EQS-Adhoc: 1&1 AG approves transformation and restructuring program for 1&1 Versatel and adjusts its 2026 EBITDA forecast
Published on 09/10/2026 at 18:50, 2 hours 49 minutes ago

Holding(s) in Company

Les Echos

Published on 09/10/2026 at 19:30, 2 hours 9 minutes ago

Availability of the 2026 Interim Financial Report
Published on 09/10/2026 at 19:30, 2 hours 9 minutes ago

Mise à disposition du Rapport Financier Semestriel 2026
Published on 09/10/2026 at 18:10, 3 hours 29 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026
Published on 09/10/2026 at 17:45, 3 hours 54 minutes ago

COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée
Published on 09/10/2026 at 17:42, 3 hours 57 minutes ago

Déclaration d'actions et de droits de vote au 31.08.2026

View all LES ECHOS COMFI WIRE